Tributary Capital Management, LLC Emergent Bio Solutions Inc. Transaction History

Tributary Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 11, 2019	SELL	$39.92 - $53.86 $5.06 Million - $6.83 Million	-126,809 Closed	0 $0
Q1 2019 Apr 17, 2019	BUY	$48.23 - $66.16 $685,975 - $940,993	14,223 Added 12.63%	126,809 $6.41 Million
Q4 2018 Jan 23, 2019	BUY	$55.63 - $73.24 $76,324 - $100,485	1,372 Added 1.23%	112,586 $6.67 Million
Q3 2018 Oct 17, 2018	BUY	$52.05 - $66.51 $2.13 Million - $2.72 Million	40,934 Added 58.24%	111,214 $7.32 Million
Q3 2018 Oct 16, 2018	SELL	$52.05 - $66.51 $1.39 Million - $1.77 Million	-26,687 Reduced 27.52%	70,280 $4.63 Million
Q2 2018 Oct 17, 2018	SELL	$48.33 - $55.64 $451,885 - $520,234	-9,350 Reduced 8.79%	96,967 $4.9 Million
Q2 2018 Jul 25, 2018	BUY	$48.33 - $55.64 $5.14 Million - $5.92 Million	106,317 New	106,317 $5.37 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tributary Capital Management, LLC with notifications on news.